PIUR IMAGING GmbH, an innovative Austrian medtech pioneer in diagnostic ultrasound imaging, is thrilled to announce a successful funding round of 6,500,000 euros. This significant capital injection will drive the continued growth and development of PIUR’s state-of-the-art technology, most notably the industry-leading PIUR tUS Infinity solution. PIUR tUS Infinity transforms any standard 2D ultrasound system into a sophisticated tomographic 3D imaging device, ushering in a new era of AI-driven ultrasound diagnostics. With this breakthrough technology, high-resolution, three-dimensional images of entire anatomical structures can be obtained using conventional 2D ultrasound transducers. This enables not only the enhancement of imaging precision but also the possibility for retrospective diagnosis, a pivotal shift from the immediate, on-the-spot evaluations that are typical in traditional ultrasound practices.
The funds will be strategically allocated to accelerate the further development of this unique platform and expand its applications, particularly in the realm of thyroid diagnostics. By incorporating smart analysis tools specifically designed for thyroid and nodule evaluation, the technology is set to substantially reduce operator dependency, optimize diagnostic workflows, and ultimately improve patient outcomes. PIUR IMAGING’s vision—to provide access to affordable, high-quality healthcare through advanced AI-driven tomographic ultrasound solutions—stands at the forefront of transforming medical imaging. This investment propels the company closer to making true AI in ultrasound a universal reality, ensuring that innovative, vendor-independent, tomographic 3D imaging becomes accessible everywhere, revolutionizing diagnostic procedures and enhancing the overall quality of care worldwide.
